Down-regulation of CD25 expression on the surface of activated tumor- infiltrating lymphocytes in human cervical carcinoma

Human Immunology

Volumn 56, Issue 1-2, 1997, Pages 39-48

  Sheu, Bor Ching ^a   Lin, Rong Hwa ^a   Ho, Hong Nerng ^b   Huang, Su Cheng ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; PHYTOHEMAGGLUTININ;

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CARCINOMA;

ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; DOWN-REGULATION; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 0031473582     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00111-0     Document Type: Article

References (36)

1. Schwartz LB, Carcangiu ML, Bradhan L, Schwartz PE. Rapid progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection Clinical opinion . Gynecol Oncol. 41:1991;255.
2. Mcdermott VG, Langer JE, Schiebler ML. Case report HIV-related rapidly progressive carcinoma of the cervix (AIDS) - CT and MRI findings . Clin Radiol. 49:1994;896.
3. Singh GS, Aikins JK, Deger R, King S, Mikuta JJ. Metastatic cervical cancer and pelvic inflammatory disease in an AIDS patient. Gynecol Oncol. 54:1994;372.
4. Pillai MR, Balaram P, Padmanabhan TK, Nair MK. Monoclonal antibody defined phenotypes of peripheral blood lymphocytes in cancer of the uterine cervix. Am J Reprod Immunol. 14:1987;141.
5. Casterllo G, Esposito G, Stellato G, Mora LD, Abate G, Germano A. Immunological abnormalities in patients with cervical carcinoma. Gynecol Oncol. 25:1986;61.
6. Mckenzie J, King A, Hare J, Fulford T, Wilson B, Stanley M. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. J Pathol. 165:1991;75.
7. Dietl JA, Horny HP, Buchholz F. Lymphoreticular cells in invasive carcinoma of the uterine cervix An immunohistological study . Int J Gynaecol Obstet. 34:1990;179.
8. Ferguson A, Moore M, Fox H. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasm An immunohistological analysis of the tumour cells and infiltrating leucocytes . Br J Obstet Gynaecol. 52:1985;551.
9. Hilders CGJM, Houbier JGA, van Ravenswaay C, Velhuizen HH, Fleuren GJ. The association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest. 69:1993;651.
10. Hilders CGJM, Houbier JGA, Krul EJT, Fleuren GJ. The expression of histocompatibility leukocyte antigens in the pathway to cervical carcinoma. Am J Clin Pathol. 101:1994;5.
11. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumor effects of tumor cells and their supernatants on proliferative responses of lymphocytes . J Immunol. 136:1986;1899.
12. Miescher S, Stoeck M, Barras QC, Barrelet L, von Fliedner V. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes, impaired response to mitogen-driven stimulation despite T-cell receptor expression. In J Cancer. 42:1988;659.
13. Ghosh AK, Moore M. Tumour-infiltrating lymphocytes in cervical carcinoma. Eur J Cancer. 28A:1992;1910.
14. Hilders CGJM, Ras L, van Eendenburg JDH, Nooyen Y, Fleuren GJ. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer. 57:1994;805.
15. Bell MC, Edwards RP, Partridge EE, Kuykendall K, Conner W, Gore H, Herrara ET, Crowley-Nowick PA. CD8+ T lymphocytes are recruited to neoplastic cervix. J Clin Immunol. 15:1995;130.
16. Garcia CF, Weiss LM, Lowder J, Komoroske C, Link MP, Levy R, Warnke RA. Quantitation and estimation of lymphocyte subsets in tissue sections Comparison with flow cytometry . Am J Clin Pathol. 87:1987;470.
17. Ritson A, Bulmer JN. Extraction of leukocytes from human decidua A comparison of dispersal techniques . J Immunol Meth. 104:1987;231.
18. Chernyshov VP, Slukvin II, Bondarenko GI. Phenotypic characterization of CD7+, CD3+, and CD8+ lymphocytes from first trimester human decidua using two-color flow cytometry. Am J Reprod Immunol. 29:1993;5.
19. Testi R, Philips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol. 143:1989;1123.
20. Matsui Y, Shapiro HM, Sheehy MJ, Christenson L, Staunton DE, Eynon EE, Yunis EJ. Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle. Eur J Immunol. 16:1986;248.
21. Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoci D, Chou CC, O'Rourke S, Taylor JMG, Giorgi JV. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol. 150:1993;3070.
22. Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, Phair JP. Multicenter AIDS Cohort Study Group CD8+ lymphocyte activation at human immunodeficiency virus type I seroconversion: Development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels . J Infect Dis. 170:1994;775.
23. Ho HN, Chao KH, Chen CK, Yang YS, Huang SC. The activation status of T and NK cells in the endometrium throughout menstrual cycle, normal and abnormal early pregnancy. Hum Immunol. 49:1996;130.
24. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol. 151:1993;4847.
25. O'Sullivan GC, Corbett AR, Shanahan F, Collins JK. Regional immunosuppression in esophageal squamous cancer. J Immunol. 157:1996;4717.
26. Hirte HW, Clark DA, O'connell G, Rusthoven J, Mazurka J. Reverse of suppression of lymphokine-activated killer cells by transforming growth factor-β on ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody. Cell Immunol. 142:1992;207.
27. Cozzolino F, Torcia M, Carossino M, Giordani R, Selli C, Talini G, Reali E, Novelli A, Pistoia V, Ferranini M. Characterization of cells from invaded lymph nodes in patients with solid tumors. J Exp Med. 166:1987;303.
28. Testi R, D'Ambrosio D, Maria DR, Santoni A. The CD69 receptor A multipurpose cell-surface trigger for hematopoietic cells . Immunol Today. 15:1994;479.
29. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today. 14:1993;49.
30. Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today. 14:1993;547.
31. Ebert EC, Roberts AI, Devereux D, Nagase H. Selective immunosuppressive action of a factor produced by colon cancer cells. Cancer Res. 50:1990;6158.
32. Waldmann TA. The IL-2/IL-2 receptor system a target for rational immune intervention . Immunol Today. 14:1993;264.
33. Rubin LA, Nelson DL. The soluble interleukin-2 receptor Biology, function, and clinical application . Ann Int Med. 113:1990;619.
34. Zlotnik A, Moore TA. Cytokine production and requirements during T-cell development. Curr Opin Immunol. 7:1995;206.
35. Zúñiga-Pflücker JC, Lenardo MJ. Regulation of thymocyte development from immature progenitors. Curr Opin Immunol. 8:1996;215.
36. Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J, Skinner JM. Lack of IL-2 cytokine expression despite IL-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma - selective expression of early activation markers. J Immunol. 156:1996;3486.